ISMB/ECCB 2019
Call for Submissions & Register to Attend!
ISMB/Call for Abstract Submissions Deadline: April 11, 2019 CAMDA Extended Deadline: May 12, 2019 |
ISMB/ECCB invites abstracts for oral/poster presentation at the conference that are topical to bioinformatics and computational biology. Abstracts can be unpublished or published (after January 1, 2018) research. All topic area are welcomed and authors are encouraged to identify their preferred community of special interest upon submission.
Communities of Special Interest Track:
• 3DSIG • Bio-Ontologies • BioVis • BOSC: Bioinformatics Open Source Conference • CAMDA • CompMS • Education • Evolution and Comparative Genomics • Function • HitSeq • MLCSB • MICROBIOME • NetBio • RegSys • RNA •
SysMod • Text Mining • TransMed • VarI • General Computational Biology
Can’t find your home COSI? ISCB welcomes submissions for all research in computational biology and bioinformatics. Simply submit to the general computational biology track above for oral and poster presentation consideration.
Abstract Submissions |
Conference Registration Deadline: June 20, 2019 |
Register to Attend |
Technology Track Submissions Deadline: May 11, 2019 |
The Technology Track allows organizations to showcase their software and/or hardware relevant to the bioinformatics/molecular biology community. Demonstrate your technology to a renowned audience at the premier comp bio conference of the year!
Prior to submitting please review the ISCB Exhibitor and Technology Track guidelines for presentations available here.
Technology Track Submissions |
Exhibitors & Sponsors Space filling up fast! |
ISMB/ECCB 2019 attracts top international scientists and key decision makers in the life sciences – experts in areas such as computer science, molecular biology and medicine, mathematics and statistics – from the world's largest and most prestigious research institutions and companies.
ISMB/ECCB 2019 is expected to attract scientific leaders from over 50 countries – that’s 50 markets!
Exhibitor & Sponsor Prospectus |
SHARE ON FACEBOOK | FOLLOW ON TWITTER | VISIT OUR PAGE |